Open access · US-GOV via ClinicalTrials.gov Clinical trial

Evaluation of Metamemory in Patients With Schizophrenia

Authors not listed

University Hospital, Clermont-Ferrand · 2011

Mitochondrial dysfunction Human Randomized controlled trial

Abstract

The purpose of this study is to determine the respective roles of aging and schizophrenia in the regulation of metamemory using a generation strategy. 4 groups will be necessary to comparison: Adult patients (18-45 years) Adult controls (18-45 years) Aged patients (≥ 59.5 years) Aged controls (≥ 59.5 years) The effects of age and the disease could lead to interaction in regulating metamemory. The effect of age would be aggravated by the disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-05-29 MST

Cite this

APA

Anonymous. (2011). Evaluation of Metamemory in Patients With Schizophrenia. <em>University Hospital, Clermont-Ferrand</em>. https://clinicaltrials.gov/study/NCT03338179

Vancouver

Anonymous. Evaluation of Metamemory in Patients With Schizophrenia. University Hospital, Clermont-Ferrand. 2011.

BibTeX

@misc{anon2011Evalua, title = {Evaluation of Metamemory in Patients With Schizophrenia}, author = {Anonymous}, journal = {University Hospital, Clermont-Ferrand}, year = {2011}, }